Journal
PRIMARY CARE DIABETES
Volume 7, Issue 1, Pages 1-10Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.pcd.2012.11.002
Keywords
Diabetes mellitus; Depression; Diabetes distress; Screening; Primary care; Cognitive behavioral therapy
Categories
Funding
- Eli Lilly
- Merck
- MSD
- Novo Nordisk
- Sanofi Aventis
- Takeda
- Bioton
- Servier
- NIHR CLAHRC
- Boehringer-Ingelheim
- Mannkind
- Pfizer
- Astra Zeneca
- Diabetes Research Foundation
- Lifescan
Ask authors/readers for more resources
Family physicians are responsible for diagnosing and treating the majority of people with type 2 diabetes mellitus and co-morbid depression. As a result of the impact of co-morbid depression on patient self-care and treatment outcomes, screening for depression in the context of a structured approach to case management and patient follow up is recommended in people with diabetes and cardiovascular disease. This review summarizes the need for improved recognition and treatment of depression in diabetes; and makes expert recommendations with regard to integrating screening tools and therapies into a busy family or general medical practice setting. (C) 2012 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available